DE60336015D1 - Menschliche Gene in Verbindung mit Krebs, davon kodierte Produkte und Anwendungen davon - Google Patents
Menschliche Gene in Verbindung mit Krebs, davon kodierte Produkte und Anwendungen davonInfo
- Publication number
- DE60336015D1 DE60336015D1 DE60336015T DE60336015T DE60336015D1 DE 60336015 D1 DE60336015 D1 DE 60336015D1 DE 60336015 T DE60336015 T DE 60336015T DE 60336015 T DE60336015 T DE 60336015T DE 60336015 D1 DE60336015 D1 DE 60336015D1
- Authority
- DE
- Germany
- Prior art keywords
- seq
- cancer
- applications
- encoded products
- dna sequences
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 5
- 206010028980 Neoplasm Diseases 0.000 title abstract 3
- 201000011510 cancer Diseases 0.000 title abstract 3
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 4
- 230000001093 anti-cancer Effects 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 101000946040 Homo sapiens Lysosomal-associated transmembrane protein 4B Proteins 0.000 abstract 1
- 102100034726 Lysosomal-associated transmembrane protein 4B Human genes 0.000 abstract 1
- 238000013459 approach Methods 0.000 abstract 1
- 238000011161 development Methods 0.000 abstract 1
- 230000018109 developmental process Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Physics & Mathematics (AREA)
- Zoology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02158110 CN1239700C (zh) | 2002-12-24 | 2002-12-24 | 一个人肝癌相关基因及其编码产物与应用 |
CNB031097863A CN1328377C (zh) | 2003-04-21 | 2003-04-21 | 人肝癌相关基因laptm4b的一个等位基因及其编码产物与应用 |
PCT/CN2003/001109 WO2004058971A1 (fr) | 2002-12-24 | 2003-12-24 | Genes se rapportant a un cancer humain, produits codes par ces genes, et applications correspondantes |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60336015D1 true DE60336015D1 (de) | 2011-03-24 |
Family
ID=32683267
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60336015T Expired - Lifetime DE60336015D1 (de) | 2002-12-24 | 2003-12-24 | Menschliche Gene in Verbindung mit Krebs, davon kodierte Produkte und Anwendungen davon |
Country Status (7)
Country | Link |
---|---|
US (3) | US7910711B2 (de) |
EP (2) | EP2230306B1 (de) |
JP (1) | JP4617257B2 (de) |
AT (1) | ATE498012T1 (de) |
AU (1) | AU2003292867A1 (de) |
DE (1) | DE60336015D1 (de) |
WO (1) | WO2004058971A1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE498012T1 (de) | 2002-12-24 | 2011-02-15 | Univ Beijing | Menschliche gene in verbindung mit krebs, davon kodierte produkte und anwendungen davon |
US8152628B2 (en) * | 2005-08-01 | 2012-04-10 | Igt | Methods and devices for authentication and licensing in a gaming network |
US8679598B2 (en) | 2010-10-08 | 2014-03-25 | Guardian Industries Corp. | Vacuum insulated glass (VIG) unit including nano-composite pillars, and/or methods of making the same |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU636435B2 (en) * | 1989-12-19 | 1993-04-29 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | Hepatocellular carcinoma oncogene |
US6878806B2 (en) * | 1997-03-14 | 2005-04-12 | Human Genome Sciences, Inc. | Human secreted protein HTEEB42 |
AU4799499A (en) * | 1998-07-24 | 2000-02-14 | Protegene Inc. | Human proteins having hydrophobic domains and dnas encoding these proteins |
AU4021700A (en) * | 1999-03-22 | 2000-10-09 | Board Of Regents, The University Of Texas System | Methods of use of beta1-integrin inhibitors |
CA2382015A1 (en) | 1999-08-17 | 2001-02-22 | Incyte Genomics, Inc. | Membrane associated proteins |
EP1242443A4 (de) * | 1999-12-23 | 2005-06-22 | Nuvelo Inc | Neue nukleinsäuren und polypeptide |
US6465620B1 (en) | 2000-01-21 | 2002-10-15 | Hyseq, Inc. | Methods and materials relating to novel von Willebrand/Thrombospondin-like polypeptides and polynucleotides |
CA2429343A1 (en) | 2000-11-17 | 2002-08-01 | Hyseq, Inc. | Nucleic acids and polypeptides |
AU2002258518A1 (en) | 2001-03-14 | 2002-09-24 | Millennium Pharmaceuticals, Inc. | Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
US20050259483A1 (en) * | 2002-09-30 | 2005-11-24 | Oncotherapy Science, Inc. | Genes and polypeptides relating to prostate cancers |
US20060188889A1 (en) * | 2003-11-04 | 2006-08-24 | Christopher Burgess | Use of differentially expressed nucleic acid sequences as biomarkers for cancer |
ATE498012T1 (de) | 2002-12-24 | 2011-02-15 | Univ Beijing | Menschliche gene in verbindung mit krebs, davon kodierte produkte und anwendungen davon |
JP2007507243A (ja) * | 2003-10-03 | 2007-03-29 | バイエル・フアーマシユーチカルズ・コーポレーシヨン | 遺伝子発現プロファイルおよび使用方法 |
-
2003
- 2003-12-24 AT AT03782072T patent/ATE498012T1/de not_active IP Right Cessation
- 2003-12-24 EP EP10153116.8A patent/EP2230306B1/de not_active Expired - Lifetime
- 2003-12-24 AU AU2003292867A patent/AU2003292867A1/en not_active Abandoned
- 2003-12-24 DE DE60336015T patent/DE60336015D1/de not_active Expired - Lifetime
- 2003-12-24 EP EP03782072A patent/EP1577390B9/de not_active Expired - Lifetime
- 2003-12-24 US US10/540,539 patent/US7910711B2/en not_active Expired - Fee Related
- 2003-12-24 WO PCT/CN2003/001109 patent/WO2004058971A1/zh active Application Filing
- 2003-12-24 JP JP2005509681A patent/JP4617257B2/ja not_active Expired - Fee Related
-
2011
- 2011-02-01 US US13/019,297 patent/US20120148589A1/en not_active Abandoned
-
2016
- 2016-05-04 US US15/146,307 patent/US9470690B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU2003292867A1 (en) | 2004-07-22 |
EP2230306A1 (de) | 2010-09-22 |
US7910711B2 (en) | 2011-03-22 |
WO2004058971A1 (fr) | 2004-07-15 |
US20120148589A1 (en) | 2012-06-14 |
US20070026395A1 (en) | 2007-02-01 |
US9470690B2 (en) | 2016-10-18 |
ATE498012T1 (de) | 2011-02-15 |
EP1577390A4 (de) | 2006-05-10 |
US20160238608A1 (en) | 2016-08-18 |
JP2006522587A (ja) | 2006-10-05 |
EP1577390B9 (de) | 2011-03-30 |
EP2230306B1 (de) | 2016-05-04 |
EP1577390A1 (de) | 2005-09-21 |
EP1577390B1 (de) | 2011-02-09 |
JP4617257B2 (ja) | 2011-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003025148A3 (en) | Novel nucleic acids and polypeptides | |
WO2002070539A3 (en) | Novel nucleic acids and polypeptides | |
WO2002081731A3 (en) | Novel nucleic acids and polypeptides | |
IL173943A0 (en) | Preventive cancer vaccine based on brother of regulator of imprinted sites molecule (boris) | |
DE69839444D1 (de) | Smad 6 und dessen anwendungen | |
WO2003029271A3 (en) | Novel nucleic acids and polypeptides | |
ATE528397T1 (de) | Bei krebs überexprimiertes gen | |
WO2004087874A3 (en) | Novel nucleic acids and polypeptides | |
ATE333520T1 (de) | Neuartige polynukleotide und polypeptide des ifnalpha-21 gens | |
DK1536006T3 (da) | Cancerantigener og anvendelse deraf | |
DE60336015D1 (de) | Menschliche Gene in Verbindung mit Krebs, davon kodierte Produkte und Anwendungen davon | |
WO2001071007A3 (en) | GENETIC POLYMORPHISM OF MxA PROTEIN AND USE THEREOF | |
WO2005049806A3 (en) | Novel nucleic acids and polypeptides | |
WO2002081654A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
WO2002072765A3 (en) | Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof | |
WO2002024910A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof | |
WO2002079252A8 (en) | Isolated human transporter protein, nucleic acid molecules encoding human transporter protein, and uses thereof | |
WO2002081657A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
WO2002079432A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
WO2002083731A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
WO2002083900A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
WO2002079227A8 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
WO2002068648A3 (en) | Isolated human ras-like proteins, nucleic acid molecules encoding these humans ras-like proteins, and uses thereof | |
WO2002077261A3 (en) | Human potassium channel | |
WO2002062977A3 (en) | Human phospholipase b-like polypeptide and uses thereof |